THOMAS SIRRINE: Open Payments
NPI 1689900276 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,784 in 174 payments from 17 companies in 2025. Trend: 2023 $2,477 · 2024 $5,256 · 2025 $20,784
Speaker / faculty: $14,923Food & beverage: $4,516Travel & lodging: $1,346
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 56 | $10,531 |
| ViiV Healthcare Company | 84 | $9,442 |
| Merck Sharp & Dohme LLC | 9 | $226 |
| Indivior Inc. | 3 | $112 |
| EMD Serono, Inc. | 4 | $110 |
| Amgen Inc. | 3 | $56 |
| Braeburn Inc. | 2 | $47 |
| Exact Sciences Corporation | 2 | $44 |
| Napo Pharmaceuticals Inc | 2 | $39 |
| PFIZER INC. | 2 | $38 |
Products named: DOVATO, Descovy, Yeztugo, APRETUDE, CABENUVA, PIFELTRO, SUBLOCADE, Biktarvy.
Industry payments across AZ — which companies pay providers there.
